Lifecore Biomedical
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Lifecore Biomedical's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24% to $128,261,000. The net income raised on $12,013,000 and profit margin reached 9%. Total operating expenses were $49,038,000.

Profit Margin

Lifecore Biomedical, Inc. (NASDAQ:LFCR): Profit margin
2015 539.25M 13.54M 2.51%
2016 541.09M -11.64M -2.15%
2017 532.25M 10.59M 1.99%
2018 524.22M 24.82M 4.74%
2019 557.55M 2.12M 0.38%
2020 590.36M -38.19M -6.47%
2021 544.16M -32.66M -6%
2022 185.78M -46.08M -24.8%
2023 103.26M -102.19M -98.96%
2024 128.26M 12.01M 9.37%

LFCR Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
128.26M103.26M185.78M544.16M590.36M557.55M524.22M532.25M541.09M539.25M
Cost of revenue
86.41M75.97M135.23M462.68M515.37M476.55M445.88M449.07M470.14M473.85M
Gross profit
41.85M27.29M50.55M81.47M74.98M81.00M78.33M83.18M70.95M65.40M
Operating exp.
Research and development
8.57M8.24M7.84M10.22M11.09M11.46M12.8M9.47M7.22M6.98M
Selling and marketing
05.1K200K100K100K1.3M1.4M1.9M2.1M0
Total operating expenses
49.03M51.25M50.47M75.58M83.28M75.52M64.75M67.68M56.74M46.94M
Operating income
9.33M-26.08M3.45M-6.86M-8.29M-8.01M11.84M15.50M-19.78M18.46M
Other income (expenses), net
183K-42.13M-55.38M-33.60M-4.76M11.65M12.11M-493K-31.15M3.01M
Income before tax
9.51M-68.70M-51.92M-40.46M-51.30M3.64M16.39M15.01M-18.85M21.47M
Income tax expense
183K301K-5.83M-7.80M-13.11M1.51M-9.36M4.33M-7.40M7.74M
Net income
12.01M-102.19M-46.08M-32.66M-38.19M2.12M24.82M10.59M-11.64M13.54M
Earnings per share
Basic EPS
0.39-3.41-1.56-1.12-1.310.070.90.39-0.430.5
Diluted EPS
0.33-3.41-1.56-1.12-1.310.070.890.38-0.430.5
Data sourceData sourceData source